Literature DB >> 11259722

The Japanese experience with vaccinating schoolchildren against influenza.

T A Reichert1, N Sugaya, D S Fedson, W P Glezen, L Simonsen, M Tashiro.   

Abstract

BACKGROUND: Influenza epidemics lead to increased mortality, principally among elderly persons and others at high risk, and in most developed countries, influenza-control efforts focus on the vaccination of this group. Japan, however, once based its policy for the control of influenza on the vaccination of schoolchildren. From 1962 to 1987, most Japanese schoolchildren were vaccinated against influenza. For more than a decade, vaccination was mandatory, but the laws were relaxed in 1987 and repealed in 1994; subsequently, vaccination rates dropped to low levels. When most schoolchildren were vaccinated, it is possible that herd immunity against influenza was achieved in Japan. If this was the case, both the incidence of influenza and mortality attributed to influenza should have been reduced among older persons.
METHODS: We analyzed the monthly rates of death from all causes and death attributed to pneumonia and influenza, as well as census data and statistics on the rates of vaccination for both Japan and the United States from 1949 through 1998. For each winter, we estimated the number of deaths per month in excess of a base-line level, defined as the average death rate in November.
RESULTS: The excess mortality from pneumonia and influenza and that from all causes were highly correlated in each country. In the United States, these rates were nearly constant over time. With the initiation of the vaccination program for schoolchildren in Japan, excess mortality rates dropped from values three to four times those in the United States to values similar to those in the United States. The vaccination of Japanese children prevented about 37,000 to 49,000 deaths per year, or about 1 death for every 420 children vaccinated. As the vaccination of schoolchildren was discontinued, the excess mortality rates in Japan increased.
CONCLUSIONS: The effect of influenza on mortality is much greater in Japan than in the United States and can be measured about equally well in terms of deaths from all causes and deaths attributed to pneumonia or influenza. Vaccinating schoolchildren against influenza provides protection and reduces mortality from influenza among older persons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259722     DOI: 10.1056/NEJM200103223441204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  220 in total

1.  Childhood Hib vaccination and pneumonia and influenza burden in US seniors.

Authors:  Steven A Cohen; Saifuddin Ahmed; Ann C Klassen; Emily M Agree; Thomas A Louis; Elena N Naumova
Journal:  Vaccine       Date:  2010-05-08       Impact factor: 3.641

2.  Influenza vaccination in young children reduces influenza-associated hospitalizations in older adults, 2002-2006.

Authors:  Steven A Cohen; Kenneth K H Chui; Elena N Naumova
Journal:  J Am Geriatr Soc       Date:  2011-01-28       Impact factor: 5.562

3.  Immunisation policy: from compliance to concordance?

Authors:  J Gervase Vernon
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

4.  [Immunisation: leaps into the future. The flu virus and syncytial respiratory virus: strategies for active immunisation].

Authors:  G Mato Chaín; A Mariano Lázaro; G Rodríguez Caravaca; J Fereres Castiel
Journal:  Aten Primaria       Date:  2002-09-15       Impact factor: 1.137

5.  A case of mural dyslexia.

Authors:  David Mant
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

Review 6.  Influenza and cardiovascular disease: is there a causal relationship?

Authors:  Mohammad Madjid; Ibrahim Aboshady; Imran Awan; Silvio Litovsky; S Ward Casscells
Journal:  Tex Heart Inst J       Date:  2004

7.  Description of a large urban school-located 2009 pandemic H1N1 vaccination campaign, New York City 2009-2010.

Authors:  Heather E Narciso; Preeti Pathela; Beth Maldin Morgenthau; Susan M Kansagra; Linda May; Allison Scaccia; Jane R Zucker
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

8.  Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.

Authors:  Nimalan Arinaminpathy; Oliver Ratmann; Katia Koelle; Suzanne L Epstein; Graeme E Price; Cecile Viboud; Mark A Miller; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

9.  Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City.

Authors:  Susan M Kansagra; Meghan D McGinty; Beth Maldin Morgenthau; Monica L Marquez; Annmarie Rosselli-Fraschilla; Jane R Zucker; Thomas A Farley
Journal:  Am J Public Health       Date:  2011-12-15       Impact factor: 9.308

Review 10.  Economic evaluations of childhood influenza vaccination: a critical review.

Authors:  Anthony T Newall; Mark Jit; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.